Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Market update

25 Sep 2014 07:27

RNS Number : 5777S
Tungsten Corporation PLC
25 September 2014
 

TUNGSTEN CORPORATION PLC 

 

("Tungsten" or the "Company")

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN NOR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

For Immediate Release 25 September 2014

 

 

Market update

Pharmaceutical and healthcare companies continue to choose Tungsten Network

Seven of the top-twelve global pharmaceutical businesses use the global e-Invoicing network

 

London, 25 September - Tungsten Network is the e-Invoicing provider of choice for the world's leading pharmaceutical and healthcare companies.

The latest organisations to select Tungsten Network include Fresenius Medical Care NA, a US-based provider of kidney dialysis services and renal care products, and Dana-Farber Cancer Institute, a world leader in cancer treatment and research.

These new customers join the global e-Invoicing network alongside long-term practitioners, such as GlaxoSmithKline, and reinforce Tungsten's strength in this industry. Seven of the twelve largest pharmaceutical companies in the world, ranked by revenue, transact with their suppliers through Tungsten Network.

"The pharmaceutical sector has been an early adopter of e-Invoicing with our first customer from the industry joining the network in 2004," says Edmund Truell, Tungsten Group CEO. "It's befitting that an industry focused on innovation is equally pioneering in its own business practices."

 

Enquiries:

 

Tungsten Corporation plc

Edmund Truell, Chief Executive Officer +44 20 3435 5680

 

Charles Stanley Securities

(Nominated Adviser and Joint Broker)

Marc Milmo/Dugald Carlean +44 20 7149 6000

 

Canaccord Genuity Limited

(Joint Broker)

Simon Bridges/Peter Stewart/Cameron Duncan +44 20 7523 8000

 

Equus Group (Communications)

Piers Hooper / Sam Barton +44 20 7223 1100

 

About Tungsten Corporation plcTungsten Corporation (LSE: TUNG) accelerates global trade by enabling customers to streamline invoice processing, improve cash-flow management and make better buying decisions from their detailed spend data.

 

Buyer organisations that join Tungsten Network, built on OB10 e-Invoicing, can reduce their invoice-processing costs by 60%. Suppliers benefit from efficiencies, greater visibility of their invoice status and peace of mind. Tungsten offers supply chain financing through Tungsten Bank and helps buying organisations profit by applying real-time spend analytics to its vast repository of line-level invoice data.

 

Tungsten serves 53% of the Fortune 500 and 66% of the FTSE 100 by connecting the world's largest companies and government agencies to their thousands of suppliers around the globe. It is compliant in 46 countries, and last year processed transactions worth over $187bn for organisations such as Alliance Data, Aviva, Cargill, Deutsche Lufthansa, General Motors, GlaxoSmithKline, Henkel, IBM, Kellogg's, and US Federal Government.

 

Tungsten Corporation joined forces with OB10 in 2013 to create the world's largest electronic trading network.

 

Contact: Sandra Higgison, Head of Global Communications, +44 20 7280 7973, sandra.higgison@tungsten-network.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALAMFTMBBTMLI
Date   Source Headline
2nd Jan 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jan 20204:35 pmRNSPrice Monitoring Extension
31st Dec 201912:40 pmRNSSecond Price Monitoring Extn
31st Dec 201912:35 pmRNSPrice Monitoring Extension
12th Dec 20197:00 amRNSPartnership with Orbian Corporation
12th Dec 20197:00 amRNSInterim Results for six months to 31 October 2019
9th Dec 20194:40 pmRNSSecond Price Monitoring Extn
9th Dec 20194:35 pmRNSPrice Monitoring Extension
29th Nov 201912:12 pmRNSHolding(s) in Company
9th Oct 20197:00 amRNSDirector/PDMR Share Dealing
20th Sep 20194:49 pmRNSDirector/PDMR Shareholding
19th Sep 20192:55 pmRNSResult of AGM
19th Sep 20197:00 amRNSTrading Update
1st Aug 20197:00 amRNSGrant of Options
25th Jul 20192:30 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSFinal Results for the year ended 30 April 2019
4th Jul 201912:07 pmRNSSecond Price Monitoring Extn
4th Jul 201912:02 pmRNSPrice Monitoring Extension
3rd Jul 20197:00 amRNSNew Chief Executive Officer
23rd May 20197:00 amRNSTrading Update
30th Apr 20197:00 amRNSInitial Results of the Operating Review
15th Apr 20197:00 amRNSDirector/PDMR Shareholding
1st Mar 201912:10 pmRNSDirector / PDMR Dealing
27th Feb 20199:29 amRNSDirector / PDMR Dealing
25th Feb 20191:45 pmRNS2019 Financial Calendar
25th Feb 20197:00 amRNSQ3 Trading Update
14th Feb 20194:40 pmRNSSecond Price Monitoring Extn
14th Feb 20194:35 pmRNSPrice Monitoring Extension
14th Feb 201912:07 pmRNSSecond Price Monitoring Extn
14th Feb 201912:02 pmRNSPrice Monitoring Extension
14th Feb 20197:00 amRNSDirectorate Change
11th Feb 20197:00 amRNSBoard Appointment
13th Dec 20187:01 amRNSDirectorate Change
13th Dec 20187:00 amRNSInterim Results for six months to 31 October 2018
4th Dec 201811:30 amRNSNotice of Interim 2019 Results
16th Nov 20184:41 pmRNSSecond Price Monitoring Extn
16th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20189:30 amRNSTungsten Network secures SdI registration in Italy
13th Nov 20189:30 amRNSTungsten Network appoints new SVP global sales
9th Oct 20187:00 amRNSDirectorate Change
21st Sep 20183:50 pmRNSResult of AGM / Appointment of Deputy Chairman
21st Sep 20187:00 amRNSAGM Statement / Trading Update
17th Sep 20189:30 amRNSGroupM UK joins Tungsten Network
28th Aug 20185:33 pmRNSReplacement: Mailing of Notice of AGM & Proxy Form
28th Aug 20184:59 pmRNSMailing of Notice of AGM and Proxy Form
23rd Aug 20187:00 amRNSBoard Appointments
22nd Aug 201812:40 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSMailing of Annual Report
10th Aug 20182:44 pmRNSHolding(s) in Company - DCIL
7th Aug 20182:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.